Pain Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy PTIE

*Your capital is at risk

$40.17

+0 (+0%)

At Close: Aug 17, 2022

Currently predicting for Mon, 29 Jun 2026

PTIE Live board

Community Bull/Bear

Target Next close

Join the PTIE prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

PTIE Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For PTIE

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

PTIE Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT PAIN THERAPEUTICS

Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The companys lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimers disease and other neurological disorders. The company was founded i...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
NMRK $15.02	1.66%	Jun 24
X XMAX $8.34	5.40%	Jun 24
JLL $299.78	5.10%	Jun 24
NESR $25.07	12.64%	Jun 23
TTEK $28.04	4.35%	Jun 23

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by